Correspondingly, in renal cell carcinoma (RCC), patients with high LAT1 expression levels exhibited shorter overall survival (OS) and progression-free survival (PFS) compared to those with low LAT1 expression levels [53]. Here, SLC7A5 is linked to renal cell carcinoma.